Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Kotak Life Launches Kotak Signature Legacy Whole Life Term Plan

    Kotak Life Launches 'Kotak Signature Legacy' Whole Life Term Plan


    Finance Outlook India Team | Monday, 16 February 2026

    Kotak Mahindra Life Insurance Company Ltd. (“Kotak Life”) today announced the launch of Kotak Signature Legacy, a whole life term plan that offers increasing life cover up to the age of 99 years; helping individuals strengthen their family’s long-term financial security and build a lasting legacy.

    Kotak Signature Legacy responds to a reality among individuals in their 40s and beyond; their protection hasn't kept pace with their progress. 

    As careers advance and responsibilities expand, financial commitments such as home loans, EMIs, long-term family goals and aspirations continue to rise. Yet many at this stage may find that their protection inadequate as existing cover is insufficient or not reviewed in a long time 

    The Kotak Signature Legacy Plan bridges this gap by offering long-term protection that grows with evolving lifestyles and responsibilities, safeguarding financial security while fostering a lasting legacy.

    Mahesh Balasubramanian, Managing Director, Kotak Life, said, “At Kotak Life, our unwavering commitment is to innovate and deliver products that truly meet our customers' evolving needs. Kotak Signature Legacy enables individuals to strengthen their growing protection needs with a plan that progresses along with their life journey. We believe this product will play a significant role in helping families achieve lasting financial security with confidence and peace of mind.”

    The product offers two plan options:

    • Legacy Plan- Whole life cover (till age 99) with increasing life cover
    • Legacy Plus Plan- Whole life cover (till age 99) with increasing life cover and return of premium 

    Also Read: Kotak Securities Projects Nifty at 29,120 by December 2026

    The product provides a host of in-built benefits, including coverage for terminal illness, an accidental death benefit during the premium payment term and an accelerated critical illness benefit after the premium payment term. Customers also gain access to health and wellness benefits, including complementary medical check-ups every three years.

    Source : Press Release


    Read More:

    Motilal Oswal Alternates Hits Final Close of Rs 8,500 Cr PE Fund

    Bajaj Broking Rides T20 Buzz with 'Seedhi Simple Investing' Campaign

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25